Current Rating and Its Significance
MarketsMOJO’s 'Sell' rating for Sampre Nutritions Ltd indicates a cautious stance towards the stock, suggesting that investors should consider reducing exposure or avoiding new purchases at this time. This rating is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential in the fast-moving consumer goods (FMCG) sector.
Quality Assessment
As of 21 July 2026, Sampre Nutritions Ltd’s quality grade remains below average. The company exhibits weak long-term fundamental strength, with an average Return on Capital Employed (ROCE) of just 1.28%. This low ROCE suggests that the company is generating limited returns on the capital invested, which is a concern for investors seeking sustainable profitability. Furthermore, operating profit growth over the last five years has been modest, at an annual rate of 18.30%, indicating restrained expansion in core earnings.
Additionally, the company’s ability to service its debt is weak, with an average EBIT to interest ratio of 0.47. This ratio implies that earnings before interest and tax are insufficient to comfortably cover interest expenses, raising concerns about financial stability and risk in adverse market conditions.
Valuation Perspective
Despite the challenges in quality, the valuation grade for Sampre Nutritions Ltd is currently very attractive. This suggests that the stock is trading at a price level that may offer value relative to its earnings and asset base. For value-oriented investors, this could present an opportunity to acquire shares at a discount compared to intrinsic worth. However, attractive valuation alone does not guarantee positive returns, especially when other factors such as financial health and technical trends are unfavourable.
Financial Trend Analysis
The financial grade for Sampre Nutritions Ltd is very positive, reflecting some encouraging signs in recent financial trends. However, this positive financial trend is tempered by the company’s overall weak fundamental strength and poor debt servicing capacity. The latest data as of 21 July 2026 shows that the stock has delivered negative returns over multiple time frames, including a 37.99% decline over the past year and a 71.26% drop year-to-date. These figures highlight significant underperformance relative to broader market indices such as the BSE500.
Moreover, the company’s operating profit growth, while positive, has not translated into sustained shareholder returns, indicating that financial improvements may not yet be sufficient to reverse the stock’s downward trajectory.
Technical Outlook
Technically, Sampre Nutritions Ltd is rated bearish. The stock’s price action over recent months has been weak, with a 60.97% decline over the past three months and a 65.95% drop over six months. Although there was a modest 1.27% gain on the most recent trading day, the overall trend remains negative. This bearish technical grade suggests that momentum indicators and chart patterns do not currently support a sustained recovery, signalling caution for traders and investors relying on technical analysis.
Stock Returns and Market Performance
As of 21 July 2026, Sampre Nutritions Ltd’s stock returns have been disappointing. The one-day gain of 1.27% is overshadowed by significant losses over longer periods: an 11.84% decline over one month, a 60.97% drop over three months, and a 37.99% fall over one year. These returns indicate persistent selling pressure and weak investor sentiment. The stock has also underperformed the BSE500 index across the last three years, one year, and three months, underscoring its relative weakness within the broader market.
Implications for Investors
For investors, the 'Sell' rating on Sampre Nutritions Ltd serves as a signal to exercise caution. The combination of below-average quality, attractive valuation, positive financial trends, and bearish technicals paints a complex picture. While the valuation may tempt value investors, the weak fundamentals and negative price momentum suggest that risks remain elevated. Investors should carefully weigh these factors and consider their risk tolerance before making investment decisions related to this stock.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
Summary of Key Metrics
To summarise, Sampre Nutritions Ltd’s current Mojo Score stands at 37.0, reflecting its 'Sell' grade. This is a notable improvement from the previous 'Strong Sell' rating, which had a score of 23 before 01 June 2026. The upgrade in rating and score indicates some progress, but the overall outlook remains cautious given the company’s financial and technical challenges.
The company’s microcap status within the FMCG sector adds an additional layer of volatility and risk, as smaller companies often face greater market fluctuations and liquidity constraints. Investors should monitor developments closely, particularly any changes in operating performance, debt servicing ability, and market sentiment.
Looking Ahead
Going forward, the key factors that could influence Sampre Nutritions Ltd’s rating and stock performance include improvements in operational efficiency, stronger earnings growth, and a stabilisation of technical trends. Should the company demonstrate sustained financial health and positive momentum, the rating could be revisited. Until then, the 'Sell' rating advises prudence and careful evaluation of risk versus reward.
Conclusion
In conclusion, Sampre Nutritions Ltd’s 'Sell' rating by MarketsMOJO, last updated on 01 June 2026, reflects a balanced assessment of its current fundamentals, valuation, financial trends, and technical outlook as of 21 July 2026. While valuation appears attractive, the company’s below-average quality and bearish technical signals warrant caution. Investors should consider these factors carefully when making portfolio decisions involving this stock.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
